
Since 1933, Chemical Engineering has honored noteworthy chemical engineering technologies…
January 2021
Comment COVID-19
By Gerald Ondrey |
Lanxess AG (Cologne, Germany; www.laxess.com) is donating 10 metric tons of its highly effective disinfectant Rely+On Virkon to hospitals, authorities and public institutions in 13 countries around the world. The powder disinfectant is diluted with water on site and is sufficient for 1 million L of disinfectant solution. It can be used to disinfect hard surfaces and equipment, for example in hospitals.
“We want to help contain the global spread of the coronavirus. With our disinfectant Rely+On Virkon we can effectively contribute to this cause,” says Anno Borkowsky, member of the Board of Management of Lanxess. “Many people, such as hospital employees, are currently risking their own health to save the lives of others. With our donation we also want to protect them.”
The product donation is being given to institutions in 13 countries. In Europe, the product is delivered to Germany, France, Italy, Great Britain, Spain and Poland, in Asia to India, Thailand, Malaysia and Singapore. On the American continent, the donation is being given to recipients in the U.S., Brazil and Mexico. “When selecting the countries, we paid attention to where the demand is particularly high and where our product is registered,” explains Anno Borkowsky.
In February, Lanxess had already donated one metric ton of Rely+On Virkon to hospitals in Wuhan, China.
Independent tests have proven that Rely+On Virkon inactivates a closely related surrogate of the currently spreading coronavirus strain. From these tests it can be concluded that Rely+On Virkon is also effective against SARS-CoV-2.
Rely+On Virkon is diluted for application and sprayed on hard surfaces and equipment. It can therefore help to reduce the risk of contamination via surfaces, door handles, tables or chairs during disinfection measures in hospitals, but also at public transport terminals, airports, shopping malls and so on.
This publication contains text, graphics, images, and other content (collectively "Content"), which are for informational purposes only. Certain articles contain the author's personal recommendations only.
RELIANCE ON ANY INFORMATION SUPPLIED IN THIS PUBLICATION IS SOLELY AT YOUR OWN RISK.
© 2021 Access Intelligence, LLC. – All Rights Reserved. Privacy Policy